Highlights
NASDAQ: RGLS       Regulus Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
0.78   +0.024 (3.17%)  0.735 - 0.78  27,000

Overview

 
Avg Volume (4 weeks):97,794
4 Weeks Range:0.57 - 0.94
4 Weeks Price Volatility (%):
56.76%
52 Weeks Range:0.503 - 1.65
52 Weeks Price Volatility (%):
24.15%
Average Price Target: 27.00
Price Target Upside/Downside: +26.22

Headlines



No recent Headlines for this stock.


Business Background

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.

  Be the first to like this.
 
actvtrader I like the 50.00 price target for yahoo!
22/10/2014 3:48 PM


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers